Literature DB >> 21862398

A shared low-frequency oscillatory rhythm abnormality in resting and sensory gating in schizophrenia.

L Elliot Hong1, Ann Summerfelt, Braxton D Mitchell, Patricio O'Donnell, Gunvant K Thaker.   

Abstract

OBJECTIVES: We hypothesized that an oscillatory abnormality that is consistently observed across various testing paradigms may index an elementary neuronal abnormality marking schizophrenia risk.
METHODS: Compared neural oscillations in resting EEG and sensory gating conditions in schizophrenia patients (n=128), their first-degree relatives (n=80), and controls (n=110) and calculated phenotypic and/or genetic correlation of the abnormal measure across these conditions.
RESULTS: Using a uniform, single trial analytical approach, we identified two prominent oscillatory characteristics in schizophrenia: (1) augmented neural oscillatory power was pervasive in medicated schizophrenia patients in most frequencies, most prominent in the theta-alpha range (4-11 Hz) across the two paradigms (all p<0.007); and (2) their first-degree relatives shared significantly augmented oscillatory energy in theta-alpha frequency in resting (p=0.002) and insufficient suppression of theta-alpha in sensory gating (p=0.01) compared with normal controls. Heritability estimates for theta-alpha related measures for resting and gating conditions ranged from 0.44 to 0.49 (p<0.03). The theta-alpha measures were correlated genetically with each other (RhoG=0.82±0.43; p<0.05).
CONCLUSIONS: Augmented theta-alpha rhythm may be an elementary neurophysiological problem associated with genetic liability of schizophrenia. SIGNIFICANCE: This finding helps to refine key electrophysiologic biomarkers for genetic and clinical studies of schizophrenia.
Copyright © 2011 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21862398      PMCID: PMC3618986          DOI: 10.1016/j.clinph.2011.07.025

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  50 in total

1.  Altered oscillatory alpha and theta networks in schizophrenia.

Authors:  C Basar-Eroglu; C Schmiedt-Fehr; S Marbach; A Brand; B Mathes
Journal:  Brain Res       Date:  2008-07-08       Impact factor: 3.252

2.  The hippocamposeptal pathway generates rhythmic firing of GABAergic neurons in the medial septum and diagonal bands: an investigation using a complete septohippocampal preparation in vitro.

Authors:  Frédéric Manseau; Romain Goutagny; Marc Danik; Sylvain Williams
Journal:  J Neurosci       Date:  2008-04-09       Impact factor: 6.167

3.  Entrainment of neuronal oscillations as a mechanism of attentional selection.

Authors:  Peter Lakatos; George Karmos; Ashesh D Mehta; Istvan Ulbert; Charles E Schroeder
Journal:  Science       Date:  2008-04-04       Impact factor: 47.728

4.  Self-generated theta oscillations in the hippocampus.

Authors:  Romain Goutagny; Jesse Jackson; Sylvain Williams
Journal:  Nat Neurosci       Date:  2009-11-01       Impact factor: 24.884

Review 5.  Abnormal neural oscillations and synchrony in schizophrenia.

Authors:  Peter J Uhlhaas; Wolf Singer
Journal:  Nat Rev Neurosci       Date:  2010-02       Impact factor: 34.870

6.  The dependence of P300 amplitude on gamma synchrony breaks down in schizophrenia.

Authors:  Judith M Ford; Brian J Roach; Ralph S Hoffman; Daniel H Mathalon
Journal:  Brain Res       Date:  2008-06-25       Impact factor: 3.252

7.  Cortical oscillatory activity is critical for working memory as revealed by deficits in early-onset schizophrenia.

Authors:  Corinna Haenschel; Robert A Bittner; James Waltz; Fabian Haertling; Michael Wibral; Wolf Singer; David E J Linden; Eugenio Rodriguez
Journal:  J Neurosci       Date:  2009-07-29       Impact factor: 6.167

8.  Hippocampal theta rhythm and its coupling with gamma oscillations require fast inhibition onto parvalbumin-positive interneurons.

Authors:  Peer Wulff; Alexey A Ponomarenko; Marlene Bartos; Tatiana M Korotkova; Elke C Fuchs; Florian Bähner; Martin Both; Adriano B L Tort; Nancy J Kopell; William Wisden; Hannah Monyer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-09       Impact factor: 11.205

9.  Increased absolute magnitude of gamma synchrony in first-episode psychosis.

Authors:  Gary Flynn; David Alexander; Anthony Harris; Thomas Whitford; Wilson Wong; Cherrie Galletly; Steve Silverstein; Evian Gordon; Leanne M Williams
Journal:  Schizophr Res       Date:  2008-07-07       Impact factor: 4.939

10.  Low-frequency neuronal oscillations as instruments of sensory selection.

Authors:  Charles E Schroeder; Peter Lakatos
Journal:  Trends Neurosci       Date:  2008-11-13       Impact factor: 13.837

View more
  25 in total

1.  Pyramidal cell selective ablation of N-methyl-D-aspartate receptor 1 causes increase in cellular and network excitability.

Authors:  Valerie M Tatard-Leitman; Catherine R Jutzeler; Jimmy Suh; John A Saunders; Eddie N Billingslea; Susumu Morita; Rachel White; Robert E Featherstone; Rabindranath Ray; Pavel I Ortinski; Anamika Banerjee; Michael J Gandal; Robert Lin; Anamaria Alexandrescu; Yuling Liang; Raquel E Gur; Karin E Borgmann-Winter; Gregory C Carlson; Chang-Gyu Hahn; Steven J Siegel
Journal:  Biol Psychiatry       Date:  2014-07-18       Impact factor: 13.382

Review 2.  A review of recent literature employing electroencephalographic techniques to study the pathophysiology, phenomenology, and treatment response of schizophrenia.

Authors:  Gary Marcel Hasey; Michael Kiang
Journal:  Curr Psychiatry Rep       Date:  2013-09       Impact factor: 5.285

3.  Frontal slow-wave activity as a predictor of negative symptoms, cognition and functional capacity in schizophrenia.

Authors:  Yu-Han Chen; Breannan Stone-Howell; J Christopher Edgar; Mingxiong Huang; Cassandra Wootton; Michael A Hunter; Brett Y Lu; Joseph R Sadek; Gregory A Miller; José M Cañive
Journal:  Br J Psychiatry       Date:  2015-07-23       Impact factor: 9.319

4.  Decreased spectral entropy modulation in patients with schizophrenia during a P300 task.

Authors:  Alejandro Bachiller; Alvaro Díez; Vanessa Suazo; Cristina Domínguez; Marta Ayuso; Roberto Hornero; Jesús Poza; Vicente Molina
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-02-05       Impact factor: 5.270

Review 5.  Delta frequency optogenetic stimulation of the thalamic nucleus reuniens is sufficient to produce working memory deficits: relevance to schizophrenia.

Authors:  Aranda R Duan; Carmen Varela; Yuchun Zhang; Yinghua Shen; Lealia Xiong; Matthew A Wilson; John Lisman
Journal:  Biol Psychiatry       Date:  2015-02-28       Impact factor: 13.382

6.  Psychophysiological endophenotypes to characterize mechanisms of known schizophrenia genetic loci.

Authors:  M Liu; S M Malone; U Vaidyanathan; M C Keller; G Abecasis; M McGue; W G Iacono; S I Vrieze
Journal:  Psychol Med       Date:  2016-12-20       Impact factor: 7.723

Review 7.  Alpha oscillations and the control of voluntary saccadic behavior.

Authors:  Jordan P Hamm; Dean Sabatinelli; Brett A Clementz
Journal:  Exp Brain Res       Date:  2012-07-11       Impact factor: 1.972

8.  Modafinil effects on middle-frequency oscillatory power during rule selection in schizophrenia.

Authors:  Michael J Minzenberg; Jong H Yoon; Yaoan Cheng; Cameron S Carter
Journal:  Neuropsychopharmacology       Date:  2014-06-26       Impact factor: 7.853

9.  Reverse translation of clinical electrophysiological biomarkers in behaving rodents under acute and chronic NMDA receptor antagonism.

Authors:  Elyse M Sullivan; Patricia Timi; L Elliot Hong; Patricio O'Donnell
Journal:  Neuropsychopharmacology       Date:  2014-09-01       Impact factor: 7.853

10.  Neural activations during auditory oddball processing discriminating schizophrenia and psychotic bipolar disorder.

Authors:  Lauren E Ethridge; Jordan P Hamm; John R Shapiro; Ann T Summerfelt; Sarah K Keedy; Michael C Stevens; Godfrey Pearlson; Carol A Tamminga; Nash N Boutros; John A Sweeney; Matcheri S Keshavan; Gunvant Thaker; Brett A Clementz
Journal:  Biol Psychiatry       Date:  2012-05-08       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.